Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 34.83% is in line with its 5-year average of 37.62%, around the middle of its 5-year range (29.00%–42.91%).
1.25% below its 12-month average of 35.27%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 38.77%.
GROSS MARGIN
34.83%
GROSS MARGIN AVG TTM
35.27%
GROSS MARGIN AVG 3Y
37.70%
GROSS MARGIN AVG 5Y
37.62%
GROSS MARGIN AVG 10Y
37.07%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.25%
CURRENT VS 3Y AVG
-7.60%
CURRENT VS 5Y AVG
-7.43%
CURRENT VS 10Y AVG
-6.04%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-40.96%
vs the sector median at left
Market Cap
$21.00B
Gross Margin
86.14%
TTM Avg
88.58%
3Y Avg
89.63%
5Y Avg
90.66%
Market Cap
$18.45B
Gross Margin
61.62%
TTM Avg
66.54%
3Y Avg
68.95%
5Y Avg
69.55%
Market Cap
$17.09B
Gross Margin
28.76%
TTM Avg
30.59%
3Y Avg
29.65%
5Y Avg
29.57%
Market Cap
$15.38B
Gross Margin
54.69%
TTM Avg
54.56%
3Y Avg
56.03%
5Y Avg
57.27%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $19.74B | 34.83% | 35.27% | 37.70% | 37.62% |
| STERIS plc (STE)vs › | $19.98B | 44.43% | 44.13% | 43.77% | 43.82% |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 86.14% | 88.58% | 89.63% | 90.66% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.45B | 61.62% | 66.54% | 68.95% | 69.55% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | 28.76% | 30.59% | 29.65% | 29.57% |
| Revvity, Inc. (RVTY)vs › | $16.00B | 52.11% | 50.55% | 50.58% | 52.43% |
| Solventum Corporation (SOLV)vs › | $15.38B | 54.69% | 54.56% | 56.03% | 57.27% |
| BioNTech SE (BNTX)vs › | $24.13B | 70.98% | 78.98% | 81.24% | 82.89% |
| Exelixis, Inc. (EXEL)vs › | $14.67B | 96.48% | 96.44% | 96.31% | 96.33% |
| Incyte Corporation (INCY)vs › | $25.40B | 92.62% | 92.70% | 93.10% | 93.74% |
Gross Margin
34.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 38.77% |
| 2026-03-31 | 32.90% |
| 2025-12-31 | 30.63% |
| 2025-09-30 | 36.83% |
| 2025-06-30 | 37.21% |
| 2025-03-31 | 35.68% |
| 2024-12-31 | 34.44% |
| 2024-09-30 | 38.90% |
| 2024-06-30 | 38.07% |
| 2024-03-31 | 41.05% |
| 2023-12-31 | 41.60% |
| 2023-09-30 | 42.91% |
| 2023-06-30 | 41.05% |
| 2023-03-31 | 41.36% |
| 2022-12-31 | 32.87% |
| 2022-09-30 | 42.87% |
| 2022-06-30 | 41.37% |
| 2022-03-31 | 42.25% |
| 2021-12-31 | 35.62% |
| 2021-09-30 | 34.70% |
| 2021-06-30 | 29.00% |
| 2021-03-31 | 25.45% |
| 2020-12-31 | 19.49% |
| 2020-09-27 | 38.98% |
| 2020-06-28 | 37.55% |
| 2020-03-29 | 34.59% |
| 2019-12-31 | 34.07% |
| 2019-09-29 | 36.21% |
| 2019-06-29 | 32.71% |
| 2019-03-30 | 32.27% |
| 2018-12-30 | 32.99% |
| 2018-09-29 | 36.31% |
| 2018-06-29 | 34.27% |
| 2018-03-30 | 36.67% |
| 2017-12-30 | 39.97% |
| 2017-09-29 | 39.44% |
| 2017-06-29 | 41.37% |
| 2017-03-30 | 39.90% |
| 2016-12-30 | 40.85% |
| 2016-09-29 | 41.98% |
| 2016-06-29 | 45.76% |
| 2016-03-30 | 41.39% |
| 2015-12-30 | 42.66% |
| 2015-09-29 | 48.80% |
| 2015-06-29 | 42.51% |
| 2015-03-30 | 44.35% |
| 2014-12-30 | 46.53% |
| 2014-09-29 | 48.58% |
| 2014-06-29 | 44.02% |
| 2014-03-30 | 43.01% |
| 2013-12-30 | 44.01% |
| 2013-09-29 | 45.75% |
